RVTY Revvity
Health Care · S&P 500
Next earnings: Mon 1 Feb 2027 · estimated
What 20 analyst firms say about Revvity: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
18 rated views · 20 analyst/firm records · 20 firms
Radar score
- S&P 500 · Top Picks · 6MNot scored · Average target is not above the current price
- S&P 500 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 16 reports on RVTY from 12 analyst firms in the last 90 days (20 firms in the past year).
Comparing each firm's latest target with its previous one: 5 raised their price target and 3 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barclays raised its target from $160.00 (set 7 Oct 2026) to $175.00 on 4 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Catherine W Schulte | Buy | 4 Aug 2026 | Conflicting reports · excluded |
| Bank of America Securities | Michael Ryskin | Hold | 15 Dec 2025 | 110.00 USD |
| Barclays | Luke E Sergott | Hold | 4 Nov 2026 | 175.00 USD |
| Bernstein | Eve Burstein | ConflictConflicting reports · excluded | 26 Jun 2026 | 115.00 USD |
| Evercore ISI | Vijay Kumar | Buy | 5 Aug 2026 | Conflicting reports · excluded |
| Goldman Sachs | Evie Koslosky | Hold | 21 Sep 2026 | Conflicting reports · excluded |
| Guggenheim | Subbu Nambi | Hold | 2 Apr 2026 | — |
| Jefferies | Tycho W Peterson | Hold | 4 Nov 2026 | 155.00 USD |
| JPMorgan | Casey Woodring | Hold | 6 May 2026 | 90.00 USD |
| KeyBanc Capital Markets | Paul Knight | Buy | 4 Sep 2026 | 165.00 USD |
| Leerink Partners | Puneet Souda | Buy | 24 Sep 2026 | 160.00 USD |
| RBC Capital Markets | Dan Leonard | Hold | 1 Sep 2026 | Conflicting reports · excluded |
| Stifel | Daniel Arias | Hold | 6 May 2026 | 100.00 USD |
| TD Cowen | Dan Brennan | Buy | 13 Oct 2026 | Conflicting reports · excluded |
| UBS | Doug Schenkel | Hold | 9 Sep 2026 | Conflicting reports · excluded |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Wells Fargo | Brandon Couillard | Hold | 3 Feb 2026 | 110.00 USD |
| William Blair | Matt Larew | Buy | 5 Oct 2026 | — |
| Wolfe Research | Mike Polark | Hold | 2 Jun 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 4 Aug 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:31 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.